indirubin-3'-monoxime has been researched along with oxidopamine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, W; Han, Y; Hu, S; Hu, Y; Lee, M; Li, G; Mak, S; Tsim, KW; Wang, Y; Xu, D; Zhang, Z | 1 |
1 other study(ies) available for indirubin-3'-monoxime and oxidopamine
Article | Year |
---|---|
Indirubin-3-Oxime Effectively Prevents 6OHDA-Induced Neurotoxicity in PC12 Cells via Activating MEF2D Through the Inhibition of GSK3β.
Topics: Animals; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; MEF2 Transcription Factors; Neurons; Neuroprotective Agents; Oxidopamine; Oximes; PC12 Cells; Rats | 2015 |